Work programme 2001


The 2001 Annual work programme defines the projects to be undertaken in the various thematic areas outlined in the 2001–03 work programme and is the first step towards implementing the goals and objectives set out within it. The content of the work programme is consistent with the aims, principles and priorities outlined in the 2001–03 work programme. It concentrates on: monitoring the drug situation; monitoring responses to the drug problem; implementing the 1997 Joint action on new synthetic drugs; and monitoring national and Community strategies and policies and their impact on the drug situation. These activities are supported by dissemination and administrative initiatives and by the Reitox network of national focal points. Special attention is also devoted to EU enlargement in accordance with the 'Enlargement strategy' adopted by the Management Board. A budget of EUR 9.1 million was adopted for the implementation of the 2001 work programme. Of this, 33 % of the resources are earmarked for monitoring the drug situation; 28 % for monitoring responses; 16 % for the Reitox network; 15 % for monitoring strategies and their impact; and 8 % for implementing the Joint action on new synthetic drugs.

Download as PDF

Table of contents

  • Explanatory memorandum: Background and foundations of the Work programme for 2001
  • The structure and the contents of the Work programme for 2001
    • The structure: thematic matrix and priority ranking
    • The content of the programmes
  • The resources
  • Annex 1: Opinion of the EMCDDA Scientific Committee on the Work programme 2001
  • Annex 2: Presentation of the Reitox, enlargement and communication/dissemination transversal activities
  • Annex 3: Reitox tasks for 2001
  • Annex 4: Structure, procedures and schedule for the preparation of the 2001 Annual report on the state of the drug phenomenon in the European Union
  • Annex 5: Resources available to implement the Work programme for 2001